Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials.

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials.

Files

Efficacy and safety of ombitasvir-paritaprevir-r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients, The MALACHITE-I-II trials..pdf(944.45 KB)

Date

2016

Authors

Streinu-Cercel, A.

Soza, Alejandro

URI

https://doi.org/10.1016/j.jhep.2015.08.015
https://repositorio.uc.cl/handle/11534/58305

Collections

Artículos de revistas